T
Thomas A. Fritz
Researcher at Heidelberg University
Publications - 36
Citations - 2680
Thomas A. Fritz is an academic researcher from Heidelberg University. The author has contributed to research in topics: Drug delivery & Liposome. The author has an hindex of 19, co-authored 36 publications receiving 2617 citations. Previous affiliations of Thomas A. Fritz include DuPont.
Papers
More filters
Patent
Therapeutic drug delivery systems
Evan C. Unger,Thomas A. Fritz,Terry Matsunaga,Varadarajan Ramaswami,David Yellowhair,Guanli Wu +5 more
TL;DR: In this article, gas-filled liposomes having encapsulated therein a drug are used for therapeutic drug delivery, and methods for employing such micro-spheres in drug delivery applications are described.
Patent
Methods of preparing gas-filled liposomes
Evan C. Unger,Thomas A. Fritz,Terry Matsunaga,VaradaRajan Ramaswami,David Yellowhair,Guanli Wu +5 more
TL;DR: In this paper, the methods of and apparatus for preparing gas-filled liposomes are described. Gas-filled Liposomes prepared by these methods are particularly useful, for example, in ultrasonic imaging applications and in therapeutic drug delivery systems.
Patent
Methods of preparing gas and gaseous precursor-filled microspheres
Evan C. Unger,Thomas A. Fritz,Terry Matsunaga,Varadarajan Ramaswami,David Yellowhair,Guanli Wu +5 more
TL;DR: In this article, temperature activated gaseous precursor-filled liposomes were used for ultrasonic imaging applications and in therapeutic drug delivery systems, for example, in drug delivery.
Patent
Targeted gas and gaseous precursor-filled liposomes
Evan C. Unger,Thomas A. Fritz,Terry O. Matsunaga,Varadarajan Ramaswami,David Yellowhair,Guanli Wu +5 more
TL;DR: In this paper, temperature activated gaseous precursor-filled liposomes were used for ultrasonic imaging applications and in therapeutic drug delivery systems, for example, in drug delivery.
Patent
Novel targeted contrast agents for diagnostic and therapeutic use
TL;DR: In this paper, the authors proposed novel contrast agents which may be used for diagnostic and therapeutic use, which include a lipid, a protein, polymer and/or surfactant, and a gas, in combination with a targeting ligand.